Spine Biologics Market to reach USD 280 billion by 2023
Spine Biologics Market Size was worth USD 226 billion in 2018 and estimated to be growing at a CAGR of 4.4%, to reach USD 280 billion by 2023
(EMAILWIRE.COM, August 13, 2018 ) In the year 2018 Global Spine Biologics Market was valued at USD 226 billion. By the year 2023, it is predicted to reach USD 280 billion with pace of 4.4% CAGR.
Spine is one of the most important support systems in the human body that enables the body to bend, twist, and safeguard spinal cord. Spine biologics are used in the treatment of spine trauma, tumors, and degenerative diseases by stimulating bone growth formation through the repair stage, remodeling stage, and inflammatory stage. Spine Biologics helps in active cellular growth and fast recovery.
Request Report Sample: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/request-sample
Factors affecting market growth:
· Growing of geriatric population across the globe. (+)
· Increasing adoption of minimally invasive surgeries. (+)
· Rise in prevalence of chronic diseases. (+)
· Increasing investments by government. (+)
· Advancement of technologies. (+)
· Introduction of new techniques for treating spine cord disorders. (+)
· Increasing healthcare expenditures. (+)
· Lack of skilled professionals. (-)
· Unfavorable reimbursement policies. (-)
Market Segmentation
The Global Spine Biologics Market is segmented on the basis of
Surgery type
· Anterior Cervical Discectomy and Fusion
· Posterior Lumbar Interbody Fusion
· Transforaminal Lumbar Interbody Fusion
· Anterior Lumbar Interbody Fusion
· Lateral Lumbar Interbody Fusion
Product type
· Bone graft
(Autograft, Allograft)
· Bone graft substitutes
(Synthetic bone grafts, Demineralized bone matrix, Bone Morphogenetic proteins)
· Platelet rich plasma
· Bone marrow aspitaye therapy.
Based on surgery type market, Anterior Cervical Discectomy and Fusion segment holds the largest market share in the global spine biologics market. On basis of product type market the bone grafts substitutes segment is expected to register a high growth rate in the global spine biologics market during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/
Key players:
Leading companies for Global Spine Biologics Market are Orthofix International N.V., RTI Surgical, Inc., SeaSpine, Zimmer Biomet Holdings, Inc., Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., and Medtronic plc, NuVasive, Inc.
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
Spine is one of the most important support systems in the human body that enables the body to bend, twist, and safeguard spinal cord. Spine biologics are used in the treatment of spine trauma, tumors, and degenerative diseases by stimulating bone growth formation through the repair stage, remodeling stage, and inflammatory stage. Spine Biologics helps in active cellular growth and fast recovery.
Request Report Sample: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/request-sample
Factors affecting market growth:
· Growing of geriatric population across the globe. (+)
· Increasing adoption of minimally invasive surgeries. (+)
· Rise in prevalence of chronic diseases. (+)
· Increasing investments by government. (+)
· Advancement of technologies. (+)
· Introduction of new techniques for treating spine cord disorders. (+)
· Increasing healthcare expenditures. (+)
· Lack of skilled professionals. (-)
· Unfavorable reimbursement policies. (-)
Market Segmentation
The Global Spine Biologics Market is segmented on the basis of
Surgery type
· Anterior Cervical Discectomy and Fusion
· Posterior Lumbar Interbody Fusion
· Transforaminal Lumbar Interbody Fusion
· Anterior Lumbar Interbody Fusion
· Lateral Lumbar Interbody Fusion
Product type
· Bone graft
(Autograft, Allograft)
· Bone graft substitutes
(Synthetic bone grafts, Demineralized bone matrix, Bone Morphogenetic proteins)
· Platelet rich plasma
· Bone marrow aspitaye therapy.
Based on surgery type market, Anterior Cervical Discectomy and Fusion segment holds the largest market share in the global spine biologics market. On basis of product type market the bone grafts substitutes segment is expected to register a high growth rate in the global spine biologics market during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/
Key players:
Leading companies for Global Spine Biologics Market are Orthofix International N.V., RTI Surgical, Inc., SeaSpine, Zimmer Biomet Holdings, Inc., Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., and Medtronic plc, NuVasive, Inc.
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results